BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2032145)

  • 21. Sea blue histiocytes in the bone marrow of variant chronic granulomatous disease with residual monocyte NADPH-oxidase activity.
    Gahr M; Jendrossek V; Peters AM; Tegtmeyer F; Heyne K
    Br J Haematol; 1991 Jun; 78(2):278-80. PubMed ID: 2064968
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation.
    Curnutte JT; Berkow RL; Roberts RL; Shurin SB; Scott PJ
    J Clin Invest; 1988 Feb; 81(2):606-10. PubMed ID: 3339133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biological and clinical aspects of chronic granulomatous disease].
    Robak T; Robak E
    Przegl Lek; 1992; 49(5):168-71. PubMed ID: 1438921
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of gp91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b558 biosynthesis.
    Porter CD; Kuribayashi F; Parkar MH; Roos D; Kinnon C
    Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):571-5. PubMed ID: 8615831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic granulomatous disease: mutations in cytochrome b558.
    Roos D; De Boer M; De Klein A; Bolscher BG; Weening RS
    Immunodeficiency; 1993; 4(1-4):289-301. PubMed ID: 8167720
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular genetic analysis of phagocyte oxidase cytochrome b558 mutations leading to chronic granulomatous disease.
    Hossle JP; Berthet F; Erny C; Seger RA
    Immunodeficiency; 1993; 4(1-4):303-6. PubMed ID: 8167722
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chronic granulomatous disease].
    Takeshige K; Minakami S
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):1048-50. PubMed ID: 3270844
    [No Abstract]   [Full Text] [Related]  

  • 28. Variant chronic granulomatous disease: modulation of the neutrophil defect by severe infection.
    Newburger PE; Luscinskas FW; Ryan T; Beard CJ; Wright J; Platt OS; Simons ER; Tauber AI
    Blood; 1986 Oct; 68(4):914-9. PubMed ID: 3019454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets.
    Leto TL; Adams AG; de Mendez I
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10650-4. PubMed ID: 7938008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic granulomatous disease.
    Goldblatt D; Thrasher AJ
    Clin Exp Immunol; 2000 Oct; 122(1):1-9. PubMed ID: 11012609
    [No Abstract]   [Full Text] [Related]  

  • 31. Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
    Newburger PE; Ezekowitz RA
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):267-76. PubMed ID: 2839459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor and immune interferon synergistically induce cytochrome b-245 heavy-chain gene expression and nicotinamide-adenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cells.
    Cassatella MA; Hartman L; Perussia B; Trinchieri G
    J Clin Invest; 1989 May; 83(5):1570-9. PubMed ID: 2496143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.
    Weening RS; De Boer M; Kuijpers TW; Neefjes VM; Hack WW; Roos D
    Clin Exp Immunol; 2000 Dec; 122(3):410-7. PubMed ID: 11122248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the defective NADPH-oxidase component in chronic granulomatous disease: a study of 57 European families.
    Casimir C; Chetty M; Bohler MC; Garcia R; Fischer A; Griscelli C; Johnson B; Segal AW
    Eur J Clin Invest; 1992 Jun; 22(6):403-6. PubMed ID: 1633835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [NADPH oxidase and cell membrane].
    Nunoi H; Matsuda I
    Rinsho Byori; 1991 Sep; Suppl 91():140-9. PubMed ID: 1661787
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic granulomatous disease.
    Schmalzer EA; Miller DR
    Prog Med Genet; 1976; 1():145-84. PubMed ID: 935507
    [No Abstract]   [Full Text] [Related]  

  • 37. The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease.
    Segal AW
    Biochem Soc Trans; 1989 Jun; 17(3):427-34. PubMed ID: 2502452
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronic granulomatous disease.
    Babior BM; Woodman RC
    Semin Hematol; 1990 Jul; 27(3):247-59. PubMed ID: 2197728
    [No Abstract]   [Full Text] [Related]  

  • 39. Activation of the human neutrophil superoxide-generating oxidase: studies in a reconstituted subcellular system.
    Clark RA; Volpp BD; Nauseef WM
    Trans Am Clin Climatol Assoc; 1989; 100():100-6. PubMed ID: 2855868
    [No Abstract]   [Full Text] [Related]  

  • 40. The respiratory burst oxidase.
    Babior BM
    Curr Opin Hematol; 1995 Jan; 2(1):55-60. PubMed ID: 9371972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.